| Authors: |
Justo N; Department of Neurobiology, Care Sciences and Society, Karolinska Institute, Stockholm, Sweden; Real World Evidence, Strategy and Analytics, ICON plc, Stockholm, Sweden. Electronic address: nahila.justo@ki.se., Espinoza MA; Department of Public Health, Pontificia Universidad Católica del Chile, Santiago, Chile., Ratto B; Novartis Pharmaceuticals Corp, East Hanover, NJ, USA., Nicholson M; Real World Evidence, Strategy and Analytics, ICON plc, Stockholm, Sweden., Rosselli D; Clinical Epidemiology and Biostatistics Department, Pontificia Universidad Javeriana, Bogatá, Colombia., Ovcinnikova O; HTA Strategy and Analytics, ICON plc, London, England, UK., García Martí S; Institute for Clinical Effectiveness and Public Health, Buenos Aires, Argentina., Ferraz MB; Federal University of São Paulo, São Paulo, Brazil., Langsam M; University Isalud, Buenos Aires, Argentina., Drummond MF; Centre for Health Economics, University of York, York, England, UK. |
